CONMED Corporation (CNMD) Financials
CNMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 2.3 billion | 1.5 billion |
2023-12-31 | 2.3 billion | 1.5 billion |
2023-09-30 | 2.3 billion | 1.5 billion |
2023-06-30 | 2.3 billion | 1.5 billion |
CNMD Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 27.1 million | 6.2 million |
2023-12-31 | 51.5 million | 5.9 million |
2023-09-30 | 40.7 million | 6.2 million |
2023-06-30 | 22.1 million | 6.4 million |
CNMD Net Income
Date | Net Income |
---|---|
2024-03-31 | 19.7 million |
2023-12-31 | 33.1 million |
2023-09-30 | 15.8 million |
2023-06-30 | 13.7 million |
CNMD Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 33.9 million | - | - |
2023-12-31 | 24.3 million | - | - |
2023-09-30 | 30.5 million | - | - |
2023-06-30 | 27.8 million | 971.5 million | - |
CNMD Shares Outstanding
CNMD Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 2.0 million | 13.6 million | 123.4 million | - |
2023-12-31 | 4.9 million | 14.0 million | 118.0 million | - |
2023-09-30 | 5.4 million | 12.5 million | 125.3 million | - |
2023-06-30 | 4.5 million | 13.6 million | 129.7 million | - |
CNMD Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 312.3 million | 140.3 million |
2023-12-31 | 327.0 million | 142.7 million |
2023-09-30 | 304.6 million | 136.5 million |
2023-06-30 | 317.7 million | 147.0 million |
CNMD
Price: $66.15
Dividend Yield: 1.29%
Forward Dividend Yield: 1.22%
Payout Ratio: 39.22%
Dividend Per Share: 0.80 USD
Earnings Per Share: 2.04 USD
P/E Ratio: 40.43
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 1.2 million
Ebitda: 23.2 millionMarket Capitalization: 2.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR10: 3.10%